1. Ehrhart N, Ehrhart EJ, Willis J, et al. Analysis of factors affecting survival in dogs with aortic body tumors. Vet Surg 2002;31:44–48.
2. Deim Z, Szalay F, Glavits R, et al. Carotid body tumor in dog: a case report. Can Vet J 2007;48:865–867.
3. Aresu L, Tursi M, Iussich S, et al. Use of S-100 and chromogranin antibodies as immunohistochemical markers in detection of malignancy in aortic body tumours in dog. J Vet Med Sci 2006;68:1229–1233.
4. Noszczyk-Nowak A, Nowak M, Paslawska U, et al. Cases with manifestation of chemodectoma diagnosed in dogs in Department of Internal Diseases with Horses, Dogs and Cats Clinic, Veterinary Medicine Faculty, University of Environmental and Life Sciences, Wroclaw, Poland. Acta Vet Scand 2010;52:35–41.
5. Yamamoto SR, Fukushima R, Hirakawa A, et al. Histopathological and immunohistochemical evaluation of malignant potential in canine aortic body tumours. J Comp Pathol 2013;149:182–191.
6. Patnaik AK, Liu SK, Hurvitz AI, et al. Canine chemodectoma (extra-adrenal paragangliomas)—a comparative study. J Small Anim Pract 1975;16:785–801.
7. Vicari ED, Brown DC, Holt DE, et al. Survival times of and prognostic indicators for dogs with heart base masses: 25 cases (1986–1999). J Am Vet Med Assoc 2001;219:485–487.
8. Ware WA, Hopper DL. Cardiac tumors in dogs: 1982–1995. J Vet Intern Med 1999;13:95–103.
Advertisement
Dr. Wolfe's present address is Sierra Animal Hospital, 427 Apollo Beach Blvd, Apollo Beach, FL 33572.
Dr. Kumar's present address is Charles River Laboratories, 640 N Elizabeth St, Spencerville, OH 45887.